{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:33:40Z","timestamp":1790303620842,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glioma patients constitute the greatest percentage of depressed neoplasm patients. These patients often require antidepressant treatment, but the effect of antidepressant drugs on glioma cells requires further evaluation. In the present study, we evaluated the effect of trifluoperazine (TFP) on the proliferation and apoptosis of glioma cells. Transcriptomic and bioinformatics analysis results suggested that antidepressant drugs, especially TFP, may upregulate the drug-resistant ability of glioma cells. A low concentration of TFP upregulated the viability of glioma cells. Colony formation and EdU assays confirmed that TFP treatment accelerates glioma cell proliferation, but no significant difference was found in the cell cycle distribution of glioma cells after treatment with TFP or control. Flow cytometry and TUNEL staining results suggested that TFP treatment decreased apoptosis in glioma cells. In addition, TFP treatment downregulated the intracellular Ca<jats:sup>2+<\/jats:sup> concentration of glioma cells. <jats:italic>In vivo<\/jats:italic> experimental results indicated that TFP treatment promoted proliferation and reduced apoptosis in xenograft tumours in nude mice. Taken together, our results suggest that a low concentration of TFP promotes proliferation and reduces apoptosis in glioma cells both <jats:italic>in vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic>. The potential harmful effects of antidepressant drugs on gliomas require further evaluation before their use in glioma patients.<\/jats:p>","DOI":"10.1038\/s41598-018-19413-y","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T14:18:09Z","timestamp":1515766689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Low concentration trifluoperazine promotes proliferation and reduces calcium-dependent apoptosis in glioma cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Yulin","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"issue":"Suppl 5","key":"19413_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","volume":"14","author":"TA Dolecek","year":"2012","unstructured":"Dolecek, T. A., Propp, J. M., Stroup, N. E. & Kruchko, C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009. Neuro Oncol 14(Suppl 5), v1\u201349 (2012).","journal-title":"Neuro Oncol"},{"key":"19413_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J Clin 65, 87\u2013108 (2015).","journal-title":"CA Cancer J Clin"},{"key":"19413_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","volume":"95","author":"M Lacroix","year":"2001","unstructured":"Lacroix, M. et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95, 190\u2013198 (2001).","journal-title":"J Neurosurg"},{"key":"19413_CR4","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3892\/ol.2013.1264","volume":"5","author":"K Sai","year":"2013","unstructured":"Sai, K., Yang, Q. Y., Shen, D. & Chen, Z. P. Chemotherapy for gliomas in mainland China: An overview. Oncol Lett 5, 1448\u20131452 (2013).","journal-title":"Oncol Lett"},{"key":"19413_CR5","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1158\/1078-0432.CCR-07-1719","volume":"14","author":"JN Sarkaria","year":"2008","unstructured":"Sarkaria, J. N. et al. Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res 14, 2900\u20132908 (2008).","journal-title":"Clin Cancer Res"},{"key":"19413_CR6","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ejca.2014.05.019","volume":"50","author":"VK Ho","year":"2014","unstructured":"Ho, V. K. et al. Changing incidence and improved survival of gliomas. Eur J Cancer 50, 2309\u20132318 (2014).","journal-title":"Eur J Cancer"},{"key":"19413_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1089\/scd.2007.0006","volume":"16","author":"MK Kang","year":"2007","unstructured":"Kang, M. K. & Kang, S. K. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev 16, 837\u2013847 (2007).","journal-title":"Stem Cells Dev"},{"key":"19413_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.1239947","volume":"343","author":"BE Johnson","year":"2014","unstructured":"Johnson, B. E. et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189\u2013193 (2014).","journal-title":"Science"},{"key":"19413_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/bjc.2012.504","volume":"108","author":"TC Hirst","year":"2013","unstructured":"Hirst, T. C. et al. Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted? Br J Cancer 108, 64\u201371 (2013).","journal-title":"Br J Cancer"},{"key":"19413_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.04.001","volume":"20","author":"L Gatti","year":"2015","unstructured":"Gatti, L., Cassinelli, G., Zaffaroni, N., Lanzi, C. & Perego, P. New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants. Drug Resist Updat 20, 1\u201311 (2015).","journal-title":"Drug Resist Updat"},{"key":"19413_CR11","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929\u20131935 (2006).","journal-title":"Science"},{"key":"19413_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nrc2044","volume":"7","author":"J Lamb","year":"2007","unstructured":"Lamb, J. The Connectivity Map: a new tool for biomedical research. Nat Rev Cancer 7, 54\u201360 (2007).","journal-title":"Nat Rev Cancer"},{"key":"19413_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1385\/MN:33:1:063","volume":"33","author":"XM Yu","year":"2006","unstructured":"Yu, X. M. The Role of Intracellular Sodium in the Regulation of NMDA-Receptor-Mediated Channel Activity and Toxicity. Mol Neurobiol 33, 63\u201380 (2006).","journal-title":"Mol Neurobiol"},{"key":"19413_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1126\/science.284.5412.339","volume":"284","author":"HG Wang","year":"1999","unstructured":"Wang, H. G. et al. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284, 339\u2013343 (1999).","journal-title":"Science"},{"key":"19413_CR15","first-page":"654291","volume":"2012","author":"XZ Zhang","year":"2012","unstructured":"Zhang, X. Z. et al. Analyzing gene expression profile in K562 cells exposed to sodium valproate using microarray combined with the connectivity map database. J Biomed Biotechnol 2012, 654291 (2012).","journal-title":"J Biomed Biotechnol"},{"key":"19413_CR16","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1164\/rccm.201207-1180OC","volume":"186","author":"CT Yeh","year":"2012","unstructured":"Yeh, C. T. et al. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer. Am J Respir Crit Care Med 186, 1180\u20131188 (2012).","journal-title":"Am J Respir Crit Care Med"},{"key":"19413_CR17","doi-asserted-by":"crossref","unstructured":"Bielecka, A. M. & Obuchowicz, E. Antidepressant drugs can modify cytotoxic action of temozolomide. Eur J Cancer Care (Engl) (2016).","DOI":"10.1111\/ecc.12551"},{"key":"19413_CR18","first-page":"3796","volume":"52","author":"LJ Brandes","year":"1992","unstructured":"Brandes, L. J. et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res 52, 3796\u20133800 (1992).","journal-title":"Cancer Res"},{"key":"19413_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.canlet.2015.11.034","volume":"371","author":"Y Xu","year":"2016","unstructured":"Xu, Y. et al. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS\/RAF\/ERK signaling pathways. Cancer Lett 371, 171\u2013181 (2016).","journal-title":"Cancer Lett"},{"key":"19413_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.canlet.2015.11.013","volume":"370","author":"SR Martins-Neves","year":"2016","unstructured":"Martins-Neves, S. R. et al. Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt\/beta-catenin signaling. Cancer Lett 370, 286\u2013295 (2016).","journal-title":"Cancer Lett"},{"key":"19413_CR21","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/jog.12691","volume":"41","author":"M Mao","year":"2015","unstructured":"Mao, M., Yu, T., Hu, J. & Hu, L. Dopamine D2 receptor blocker thioridazine induces cell death in human uterine cervical carcinoma cell line SiHa. J Obstet Gynaecol Res 41, 1240\u20131245 (2015).","journal-title":"J Obstet Gynaecol Res"},{"key":"19413_CR22","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.3892\/mmr.2015.3967","volume":"12","author":"T Yin","year":"2015","unstructured":"Yin, T. et al. Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model. Mol Med Rep 12, 4103\u20134108 (2015).","journal-title":"Mol Med Rep"},{"key":"19413_CR23","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","volume":"149","author":"E Sachlos","year":"2012","unstructured":"Sachlos, E. et al. Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells. CELL 149, 1284\u20131297 (2012).","journal-title":"CELL"},{"key":"19413_CR24","first-page":"1543","volume":"8","author":"M Lu","year":"2015","unstructured":"Lu, M. et al. Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis. Onco Targets Ther 8, 1543\u20131552 (2015).","journal-title":"Onco Targets Ther"},{"issue":"Suppl 5","key":"19413_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-9-S5-S4","volume":"9","author":"Q Wen","year":"2015","unstructured":"Wen, Q. et al. Connectivity mapping using a combined gene signature from multiple colorectal cancer datasets identified candidate drugs including existing chemotherapies. BMC Syst Biol 9(Suppl 5), S4 (2015).","journal-title":"BMC Syst Biol"},{"key":"19413_CR26","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1177\/0960327110396523","volume":"30","author":"JM Chien","year":"2011","unstructured":"Chien, J. M. et al. The mechanism of sertraline-induced [Ca2+]i rise in human OC2 oral cancer cells. Hum Exp Toxicol 30, 1635\u20131643 (2011).","journal-title":"Hum Exp Toxicol"},{"key":"19413_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1158\/1535-7163.MCT-16-0169-T","volume":"16","author":"S Kang","year":"2017","unstructured":"Kang, S. et al. Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R. Mol Cancer Ther 16, 217\u2013227 (2017).","journal-title":"Mol Cancer Ther"},{"key":"19413_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.brainresbull.2010.12.008","volume":"84","author":"S Liu","year":"2011","unstructured":"Liu, S., Han, Y., Zhang, T. & Yang, Z. Protective effect of trifluoperazine on hydrogen peroxide-induced apoptosis in PC12 cells. Brain Res Bull 84, 183\u2013188 (2011).","journal-title":"Brain Res Bull"},{"key":"19413_CR29","doi-asserted-by":"publisher","first-page":"25308","DOI":"10.18632\/oncotarget.4490","volume":"6","author":"K Yuan","year":"2015","unstructured":"Yuan, K. et al. Calmodulin antagonists promote TRA-8 therapy of resistant pancreatic cancer. Oncotarget 6, 25308\u201325319 (2015).","journal-title":"Oncotarget"},{"key":"19413_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5306\/wjco.v6.i6.299","volume":"6","author":"M Bowie","year":"2015","unstructured":"Bowie, M. et al. Fluoxetine induces cytotoxic endoplasmic reticulum stress and autophagy in triple negative breast cancer. World J Clin Oncol 6, 299\u2013311 (2015).","journal-title":"World J Clin Oncol"},{"key":"19413_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00221-006-0678-1","volume":"177","author":"DSP Souza","year":"2007","unstructured":"Souza, D. S. P., Saraiva, D. F., Ferraz, D. C. D., Scofano, H. M. & de Carvalho-Alves, P. C. Trifluoperazine protects brain plasma membrane Ca(2+)-ATPase from oxidative damaging. Exp Brain Res 177, 347\u2013357 (2007).","journal-title":"Exp Brain Res"},{"key":"19413_CR32","first-page":"235","volume":"6","author":"R Situ","year":"1987","unstructured":"Situ, R. et al. Establishement of human brain malignant glioma cell line (SWO-38) and observation of its biologic properties. Chin J Cancer 6, 235\u2013238 (1987).","journal-title":"Chin J Cancer"},{"key":"19413_CR33","first-page":"34","volume":"3","author":"XY Zhong","year":"2000","unstructured":"Zhong, X. Y., Chen, Y. X. & Ye, S. F. Establishment of two cell sublines from SWO-38 glioma cells: an immunohisto-chemical and ultrastructural Study. Int J Modern Cancer Therapy 3, 34\u201337 (2000).","journal-title":"Int J Modern Cancer Therapy"},{"key":"19413_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neulet.2012.09.022","volume":"529","author":"C Lin","year":"2012","unstructured":"Lin, C., Liang, Y., Zhu, H., Zhang, J. & Zhong, X. R280T mutation of p53 gene promotes proliferation of human glioma cells through GSK-3beta\/PTEN pathway. Neurosci Lett 529, 60\u201365 (2012).","journal-title":"Neurosci Lett"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19413-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19413-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19413-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T01:09:06Z","timestamp":1671584946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-19413-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["19413"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-19413-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,18]]},"assertion":[{"value":"12 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1147"}}